๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I Clinical Trial and Pharmacokinetics of Intravesical Mitomycin C in Dogs with Localized Transitional Cell Carcinoma of the Urinary Bladder

โœ Scribed by A.H. Abbo; D.R. Jones; A.R. Masters; J.C. Stewart; L. Fourez; D.W. Knapp

Book ID
118095262
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
182 KB
Volume
24
Category
Article
ISSN
0891-6640

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy of intravesical mitomycin C in
Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder
โœ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 301 KB ๐Ÿ‘ 1 views

We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll

Mitomycin c in the treatment of metastat
Mitomycin c in the treatment of metastatic transitional cell carcinoma of urinary bladder
โœ K. Early; E. G. Elias; A. Mittelman; D. Albert; G. P. Murphy ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 515 KB

Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr